ENXTPA:BIMMedical Equipment
bioMérieux (ENXTPA:BIM) Stock Could Be 23.7% Undervalued After Salmonella Test Launch
bioMérieux (ENXTPA:BIM) has launched GENE-UP TYPER SLM, a patented real-time PCR assay that helps food manufacturers quickly discriminate Salmonella enterica subspecies enterica and trace contamination sources through a machine learning powered web application.
See our latest analysis for bioMérieux.
Despite the product launch, bioMérieux’s recent share price performance has been weak. The stock is at €69.0, with a 90 day share price return that declined 23.93% and a 1 year total shareholder...